{"rouge": [{"rouge-1": {"r": 0.39814814814814814, "p": 0.5276073619631901, "f": 0.4538258526175674}, "rouge-2": {"r": 0.16569767441860464, "p": 0.2590909090909091, "f": 0.20212765481615622}, "rouge-l": {"r": 0.35185185185185186, "p": 0.4662576687116564, "f": 0.40105540406875473}}], "ozwell": {"s1": "The two notes are very similar. Both discuss a 23-year-old female patient with severe depression, obesity, and diabetes who experienced a prolonged seizure managed with intravenous benzodiazepine. They explore the potential relationship between diabetes and epilepsy, particularly the role of hypoglycemia in seizures. Both notes mention elevated blood sugar levels during ECT and the possibility of a decline in blood sugar levels due to fasting. They also address the patient's obesity and the absence of sleep-related respiratory disorders, despite the risk factors associated with obesity. The plan to monitor the patient's condition and schedule a follow-up appointment is also consistent in both notes."}}